Evonik Industries (FRA:EVK) Given a €29.00 Price Target by Baader Bank Analysts

Baader Bank set a €29.00 ($33.72) target price on Evonik Industries (FRA:EVK) in a research note published on Monday morning, Borsen Zeitung reports. The firm currently has a buy rating on the stock.

EVK has been the subject of a number of other reports. Morgan Stanley set a €34.00 ($39.53) target price on Evonik Industries and gave the company a buy rating in a research note on Monday, July 15th. Kepler Capital Markets set a €25.00 ($29.07) target price on Evonik Industries and gave the company a sell rating in a research note on Tuesday, May 7th. UBS Group set a €23.00 ($26.74) target price on Evonik Industries and gave the company a sell rating in a research note on Thursday, August 1st. Nord/LB set a €24.00 ($27.91) target price on Evonik Industries and gave the company a neutral rating in a research note on Thursday, August 1st. Finally, Deutsche Bank set a €40.00 ($46.51) target price on Evonik Industries and gave the company a buy rating in a research note on Friday, August 2nd. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and ten have given a buy rating to the stock. The stock currently has a consensus rating of Hold and an average target price of €30.05 ($34.94).

EVK opened at €21.23 ($24.69) on Monday. The stock has a 50-day moving average price of €24.87 and a 200-day moving average price of €25.14. Evonik Industries has a 12-month low of €26.78 ($31.14) and a 12-month high of €32.97 ($38.34).

About Evonik Industries

Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.

See Also: Debt-To-Equity Ratio

Analyst Recommendations for Evonik Industries (FRA:EVK)

Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.